What are the targeted drugs for the treatment of Colon Cancer Metastasis?
There were mainly the following types of targeted drugs for the treatment of Colon Cancer Metastasis: - Bevacizumi: Usually combined with chemotherapy, it is suitable for patients with unresected liver cancer. It was a kind of monoclone anti-tumor that could combine with the growth factor of blood vessels to suppress the growth of tumor vessels and the formation of new blood vessels, thereby achieving the purpose of suppressing tumor growth and migration. - Cetuxed: It can be used alone or in combination with chemotherapy to treat liver metastasizing from patients with hepatic cancer, but it only has a good effect on patients with wild-type RAS and BRAF genes. Its mechanism of action was that it could bind to the Epidermal Growth factor receptor and block the signal pathway in the cell, thereby suppressing the growth of cancer cells and inducing cancer cells to die. - Regorafenib: An oral targeted drug. It is also used in clinical treatment of colonic cancer, but the specific effects need further research. Read more exciting novels for free
What are the targeted drugs for the treatment of large B cell cancer?
The targeted drugs commonly used in the clinical treatment of large B-cell leukemia (large B-cell cancer) mainly included rituxed, cyclosporine, iglitinib, and sidariline. Rituanxian is a human-mouse chimera monoclone, which can specifically bind to the membrane protein, CD20. It is suitable for patients with relapsed or drug-resistant B-cell leukemia. It can prolong the patient's progression free survival time and alleviate the resistance of B-cells to cyclosporine. Cyclosporine is a kind of nitrogen mustard drug, which can be converted into the active Metabolite 5 -Phosphates in the body, which plays an anti-tumor role inside and outside the cell. It can be used for the treatment of many malignant tumors, including leukemia. Iglitini was a small molecular anti-tumor targeted drug that could inhibit the RAF kinases on the surface of B cells and the growth of cancer cells. It was suitable for various B-cell lysmphomas, including diffuse large B-cell lysmphoma, etc.; Cedaramin was a kind of nitrogen mustard receptor Tyrosin Kinase Inhibition, which could inhibit tumor cell growth factor receptor, RAF kinases, etc., and had a certain treatment effect on B-cell lysmphoma. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What is the survival rate of targeted drugs in the treatment of advanced lung cancer?
There was a large individual difference in the survival rate of patients with advanced lung cancer after taking targeted drugs. The time from the start of treatment to disease progression or death was 9.2 - 18.9 months, and the general overall survival period was 21.6 - 36 months. Some studies had shown that the average survival time for late-stage lung cancer patients with targeted drugs was about three years, but there were also cases where it was as short as one or two years and as long as ten years. According to the data, after comprehensive treatment, the 2-year survival rate of stage IUA lung cancer patients was 23%, the 5-year survival rate was 10%, and the medium survival time was 11.5 months. For stage IUA lung cancer patients who had multiple metastasies, the 2-year survival rate was 10%, and the medium survival time was 6 months. In addition, in some studies, the 1-year, 2-year, 3-year, 4-year, and 5-year overall survival rates of the control group (first-line therapy with a combination of a combination The patient's physical condition, the effect of the targeted therapy, whether the attitude was positive, the degree of cooperation with the treatment, whether the patient had underlying diseases, and the support, care, and financial investment of the family would all affect the survival rate. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the 32 targeted drugs for treating cancer?
The following are some cancer-targeted drugs: - The targeted drugs for the first-line treatment of lung adenomas and lung cancer with egfr-mutation included osimertinib, dacotinib, gefitini, erlotinib, icotinib, afartinib, bevacidating, and ramulatumab; the second-line treatment (T790M positive) included osimertinib and amitini; the first-line treatment of ALK mutation included alectinib, crizotinib, ceritini, and bugatini; the second-line treatment of crizotinib-resistant included alectinib, bugatinib, and ceritini; and the second-generation targeted drugs included lorlatini. - There were also palinosetron capsules, metoclopramine tablets, ondansetron capsules, and aprepitant capsules. - Larotinib can be used to treat all advanced solid tumors with NtrK gene fusion, including 21 types of cancer, such as thyreoid cancer, myospasm, primary central nervous system tumor, sialoadenoma, Coloembryonic cancer, leukemia, breast cancer, bone sarcomas, histisarcomas, bile duct cancer, hepatic cancer, congenital mesogenic kidney cancer, primary unknown cancer, apexical cancer, liver cancer, bladder cancer, and cervical cancer. However, the number of targeted drugs explicitly mentioned at present did not reach 32, and the complete information of 32 cancer targeted drugs could not be provided. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
There are several types of breast cancer targeted drugs
There were mainly the following types of breast cancer targeted drugs: 1. Anti-neoplastic targeted drugs: There are intravenous preparations and oral drugs, but the effect in the treatment of breast cancer is not ideal. For example, bevacidol (Avastin) will be considered in some cases. 2. Anti-Her- 2 targeted drugs: targeted at HER - 2 positive patients, it is the most important targeted drug for breast cancer, mainly including trastuzumab (Herceptin), pertubizab, dm- 1, lapatini, etc. The prerequisite for use was that the patient was positive for HER - 2 (+++ in the immune tissue test). If the immune tissue test was ++, the patient would need to undergo a further FISH test. The patient could only be used if the FISH test was positive. If the immune tissue test was + or-, the patient could not be used. 3. A targeted drug for patients with fetal mutations in the Brca lineage: The main drug is olaparib, which is used to treat patients with metastasizing breast cancer who have harmful or suspected harmful mutations in the Brca lineage and who are negative for the human embryonic growth factor receptor 2 (HEL2). 4. Immune therapy (in a sense, it was also a targeted drug): Anti-PD- 1/PD-L1 Monoclone Antibodies, which essentially relieved immune suppression and activated immune cells to kill cancer cells. 5. mTO inhibition drugs, such as everolimus and sirolimus, can inhibit the activation of the mTO signaling pathway, thereby suppressing the growth and metabolism of tumor cells. 6. Other targeted therapy drugs, such as Parp inhibition drugs, CD 4/6 inhibition drugs, etc. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Real Colon Cancer Stories: Coping with Diagnosis and Treatment
In a real colon cancer story, when a person is diagnosed, the first reaction is often shock. But many patients find that getting as much information as possible helps. For example, some patients read up on the latest research about colon cancer treatments. They learn about the different types of surgeries like colectomy. Knowing these details can make them feel more in control during the treatment process.
Is it always effective to take targeted drugs for lung cancer?
The effect of targeted drugs on lung cancer patients was not very good. Target drugs could not cure lung cancer. Although they could prolong survival time, they could not always be effective. There were very few driver mutations in lung cancer, so there were relatively few targeted drugs that could be used. When using targeted drugs, it was necessary to find the target of lung cancer and could not be used blindly. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is it useful to take targeted drugs for esophagus cancer metastasizing?
At present, a variety of targeted drugs were available for the treatment of esophagus cancer, including new small molecules multi-target Tyrosin Kinase Inhibition, drugs that targeted HEL2, cetuxed that targeted the egFr target, and bevacizumb that targeted the veg-like growth factor target, etc. There was also a combination of PD1 - 1 inhibition and targeted HEL2 for the treatment of cancer at the gastric-esophagus junction. Chinese studies have shown that as a new small-molecular multi-target Tyrosinase Kinase Inhibition, anlotinib and apitini have a certain effect in the treatment of esophagus cancer. The combination therapy of trastuzumab-targeted to HEL2 and PD1 inhibition drugs (such as pembrolizumab) combined with chemotherapy can be used as the first-line treatment for cancer of the gastroesophagus junction, advanced gastric cancer with HEL2 positive, and esophagus cancer. In the second-line treatment of China guidelines for the treatment of esophagus cancer, level II recommendations were given to anlotinib (Class 2A) and apitini (Class 3). However, there were no phase III clinical trials to prove that molecular targeted drugs could prolong the survival of patients with esophagus cancer. The effect of targeted therapy needed further study. In general, molecular targeted therapy had a certain clinical value for the treatment of patients with esophagus cancer, including those with metastasizing, but it still needed further in-depth research. These drugs must be used under the guidance of a professional doctor. It is not recommended for patients to buy and take them themselves to avoid serious adverse reactions. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What targeted drugs can be taken for oral cancer?
The targeted drugs for oral squamous-cell cancer included pabolizumab injection, trastubizab for injection, erlotinib, gefitinib, cetuxed, nivaliumab, etc. Pabolizub injection can be used to treat advanced non-small cell lung cancer, advanced gastric cancer, oral Squamoma, etc.; Trastuzu for injection can be used to treat metastasized breast cancer, metastasized gastric cancer, oral Squamoma, etc.; Erlotinib is suitable for patients with advanced non-small cell lung cancer who have a mutation in Exon 19 or L858 of the Epidermal growth factor receptor Tyrosin Kinase gene. It can block the egf-signaling pathway to inhibit the growth of tumor cells; Gefitini can be used for the treatment of patients with locally advanced or metastasized non-small cell lung cancer who have failed at least one previous chemotherapy program. It can selectively inhibit the activity of EGFR protein protein. Cetuxed is suitable for the auxiliary treatment of RAS gene wild-type Colon Cancer, Rectal Cancer, and Stomach Cancer. It can be used in combination with radiation to improve the efficacy. Nivaliumab is suitable for the treatment of patients with advanced liver cancer who have failed previous systematic treatment. It activates T cells, allowing them to recognize and attack tumor cells that express the PD - 1 receptor. When using these drugs, you must follow the doctor's advice and pay attention to their respective conditions and precautions. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the targeted drugs for small cell lung cancer?
Currently, targeted drugs specifically for small cell lung cancer have not been approved for marketing, but there are other types of targeted drugs that can be used to treat small cell lung cancer. For example, anlotinib, a new small-molecular multi-target tropinase inhibition drug, has anti-tumor vasodification effects and has been used in the third-line treatment of small cell lung cancer; Nivaliumab was approved for the treatment of patients with metastasized small cell lung cancer who had previously received platinum-based chemotherapy and at least one other therapy; Drulimucomab can be used in combination with chemotherapy to treat extensive small cell lung cancer; Atelibiza can be used in combination with chemotherapy to treat first-line treatment of extensive small cell lung cancer; There were also apatinib, niraparik, pembrolizib, and so on. In addition, as an anti-viral and anti-tumor immune regulator, Interferon can be used in the treatment of lung cancer; Bendamustine is an egf-receptor antagonist, which can reduce the side effects of patients and achieve a certain effect; Imatini suppresses the growth of cancer cells, prolonging the survival of patients and reducing adverse reactions; Perindopril Fumarate is an oral neo-vasodilator, which can suppress tumor neo-vasodillations and slow down tumor growth. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the names of targeted drugs for head and neck cancer?
As for head and neck tumors, because most head and neck tumors occur in the mucus membrane, more than 90% of them are positive for the receptor for the growth factor of the human skin. Target drugs such as cetuxed mainly act on the growth factor of the human skin. Cetuxed combined with chemotherapy can achieve better efficacy in the treatment of head and neck tumors and reduce tumor relapse and migration. In addition, Bevacobin, Duostat, etc. can inhibit tumor neoplasia and thus tumor growth. However, there was no specific mention of targeted drugs for head and neck adenomas. There was only information on targeted drugs for head and neck tumors. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>